[Clinical findings in podophyllotoxin derivatives (SP-I-SP-G) in malignant tumors].
D000328:Adult; D000368:Aged; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011033:Podophyllin / Q000627:therapeutic use; D011035:Podophyllum / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D011033:Podophyllin